News for Hemogenyx Pharmaceuticals Plc (HEMO.L)

Published at

Jun 3, 2025 7:00 PM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRT

HOPHF HEMO.L CAPD.L

Read more →
Published at

Jun 3, 2025 11:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests

Second Patient Treated with HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation LONDON, UNITED KINGDOM / ACCESS Newswire / June 3, 2025 / Hemoge

HOPHF HEMO.L CAPD.L

Read more →
Published at

May 14, 2025 11:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol

Amendment to Clinical Protocol for HG-CT-1 to Include Pediatric Patients with R/R AML LONDON, UNITED KINGDOM / ACCESS Newswire / May 14, 2025 / Hemogenyx Pharma

HOPHF HEMO.L CHRT.L CAPD.L

Read more →
Published at

Apr 28, 2025 11:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces Final Results

LONDON, UNITED KINGDOM / ACCESS Newswire / April 28, 2025 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and

HOPHF HEMO.L CAPD.L

Read more →
Published at

Apr 28, 2025 9:15 AM

by gurufocus.com

positive

positive

Hemogenyx Pharmaceuticals PLC Announces Final Results | HOPHF Stock News

Hemogenyx Pharmaceuticals (LSE: HEMO) initiates Phase I clinical trials for HG-CT-1. The company secures £5.2 million in funding through share issuance

HOPHF HEMO.L

Read more →
Published at

Apr 3, 2025 11:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report

Hemogenyx Pharmaceuticals Files Annual IND Report with FDA for HG-CT-1 CAR-T Therapy for AML LONDON, UK / ACCESS Newswire / April 3, 2025 / Hemogenyx Pharmaceut

HOPHF HEMO.L CAPD.L

Read more →
Published at

Mar 24, 2025 10:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces First Patient Safety

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET AB

HOPHF HEMO.L CAPD.L

Read more →
Published at

Mar 17, 2025 10:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials

Recruitment of Second Patient for HG-CT-1 Clinical Trial LONDON, GB / ACCESS Newswire / March 17, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to

HOPHF HEMO.L CAPD.L

Read more →
Published at

Mar 11, 2025 10:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces Institutional Investment

Institutional backing of £709,200 for continuing Phase 1 Clinical Trials LONDON, UNITED KINGDOM / ACCESS Newswire / March 11, 2025 / Hemogenyx Pharmaceuticals

HOPHF HEMO.L CAPD.L

Read more →
Published at

Feb 24, 2025 10:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET AB

HOPHF HEMO.L CAPD.L

Read more →
Published at

Dec 30, 2024 10:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site

Hemogenyx Pharmaceuticals Opens First Clinical Site for HG-CT-1 Phase I TrialPatient Recruitment Begins for CAR-T Cell Therapy Targeting Relapsed/Refractory Acu

HOPHF HEMO.L CAPD.L

Read more →
Published at

Dec 9, 2024 10:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed

Hemogenyx Pharmaceuticals Successfully Completes the Site Initiation Visit of the First Clinical Site for Phase I Clinical Trial of HG-CT-1 LONDON, UNITED KINGD

HOPHF HEMO.L CAPD.L

Read more →
Published at

Nov 22, 2024 6:00 PM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New Articl

HOPHF HEMO.L CAPD.L

Read more →
Published at

Nov 22, 2024 10:00 AM

by gurufocus.com

mixed

mixed

Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial

Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK / ACCESSWIRE / November 22, 2024 / Hemogenyx Pharma

HOPHF HEMO.L CAPD.L

Read more →
Published at

Jun 17, 2024 8:56 PM

by marketscreener.com

positive

positive

Hemogenyx Pharmaceuticals updates on leukemia treatment

Hemogenyx Pharmaceuticals PLC - biopharmaceutical company focused on treatments for blood diseases - Updates on its ongoing activities and progress. Says an additional US medical centre has been...

HOPHF HEMO.L

Read more →
Published at

Apr 25, 2024 1:20 PM

by marketscreener.com

mixed

mixed

EARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payout

The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- LSL Property Services PLC -...

TAN.L TUNE.L LSLPF LSL.L HOPHF HEMO.L FOCIF CKT.L DSG.L

Read more →
Published at

Nov 27, 2023 11:56 AM

by marketscreener.com

positive

positive

Hemogenyx shares up as says CBR platform a potential cancer treatment

Hemogenyx Pharmaceuticals PLC on Monday said its chimeric based receptor platform could potentially be used to treat cancer and viral diseases. Shares in Hemogenyx rose 11% to 2.78 pence each in...

HOPHF HEMO.L

Read more →
Published at

Sep 18, 2023 3:38 PM

by marketscreener.com

mixed

mixed

Avingtrans buys Adaptix, TPXimpact sells Questers

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- First Tin PLC - London-based, Germany and Australia-focused...

HOPHF HEMO.L BSFA.L AVG.L CRTM.L

Read more →
Published at

Jul 10, 2023 11:28 AM

by marketscreener.com

positive

positive

Hemogenyx says Hemo-Car-T treatment placed on clinical hold by US FDA

Hemogenyx Pharmaceuticals PLC on Monday said it has received a review letter from the US Food & Drug Administration confirming its placement of Hemo-Car-T on clinical hold. Hemogenyx shares rose...

HOPHF HEMO.L

Read more →
Published at

Mar 23, 2023 9:34 PM

by marketscreener.com

positive

positive

Fragrant Prosperity to buy Hi 55, Oscillate talks end

The following is a round-up of updates by London-listed companies, issued on Thursday not separately reported by Alliance News: ---------- Seraphine Group PLC - London-based maternity wear retailer -... | March 23, 2023

RKH.L RCKHF HOPHF HEMO.L

Read more →